Steven Cohen's JAZZ Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 175,000 shares of Jazz Pharmaceuticals plc (JAZZ) worth $29.75 M, representing 0.03% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in JAZZ, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2021, adding 749,300 shares. Largest reduction occurred in Q1 2022, reducing 487,650 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Jazz Pharmaceuticals plc (JAZZ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Jazz Pharmaceuticals plc (JAZZ) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +163,145 | Add 1376.17% | 175,000 | $170.00 |
| Q3 2025 | +11,855 | New Buy | 11,855 | $131.81 |
| Q2 2025 | -173,870 | Sold Out | 0 | $0.00 |
| Q1 2025 | +89,719 | Add 106.62% | 173,870 | $124.15 |
| Q4 2024 | -184,632 | Reduce 68.69% | 84,151 | $123.15 |
| Q3 2024 | +86,768 | Add 47.67% | 268,783 | $111.41 |
| Q2 2024 | +182,015 | New Buy | 182,015 | $106.73 |
| Q4 2023 | -64,624 | Sold Out | 0 | $0.00 |
| Q3 2023 | +64,624 | New Buy | 64,624 | $129.44 |
| Q2 2023 | -87,909 | Sold Out | 0 | $0.00 |
| Q1 2023 | +76,109 | Add 644.99% | 87,909 | $146.33 |
| Q4 2022 | -380,100 | Reduce 96.99% | 11,800 | $159.31 |
| Q3 2022 | +98,631 | Add 33.63% | 391,900 | $133.29 |
| Q2 2022 | -182,905 | Reduce 38.41% | 293,269 | $156.01 |
| Q1 2022 | -487,650 | Reduce 50.60% | 476,174 | $155.67 |
| Q4 2021 | +214,524 | Add 28.63% | 963,824 | $127.40 |
| Q3 2021 | +749,300 | New Buy | 749,300 | $130.21 |
| Q4 2020 | -326,289 | Sold Out | 0 | $0.00 |
| Q3 2020 | -19,850 | Reduce 5.73% | 326,289 | $142.59 |
| Q2 2020 | +323,439 | Add 1424.84% | 346,139 | $110.34 |
| Q1 2020 | +22,700 | New Buy | 22,700 | $99.74 |
| Q4 2019 | -216,943 | Sold Out | 0 | $0.00 |
| Q3 2019 | +216,943 | New Buy | 216,943 | $128.14 |
| Q3 2018 | -35,000 | Sold Out | 0 | $0.00 |
| Q2 2018 | -15,000 | Reduce 30.00% | 35,000 | $172.31 |
| Q1 2018 | +50,000 | New Buy | 50,000 | $151.00 |
| Q4 2017 | -74,700 | Sold Out | 0 | $0.00 |
| Q3 2017 | +41,800 | Add 127.05% | 74,700 | $146.25 |
| Q2 2017 | -344,004 | Reduce 91.27% | 32,900 | $155.50 |
| Q1 2017 | +133,804 | Add 55.04% | 376,904 | $145.13 |
| Q4 2016 | -109,100 | Reduce 30.98% | 243,100 | $109.03 |
| Q3 2016 | +133,300 | Add 60.90% | 352,200 | $121.48 |
| Q2 2016 | +144,400 | Add 193.83% | 218,900 | $141.31 |
| Q1 2016 | +74,500 | New Buy | 74,500 | $130.55 |
| Q4 2015 | -21,915 | Sold Out | 0 | $0.00 |
| Q3 2015 | +21,915 | New Buy | 21,915 | $132.83 |
Steven Cohen's Jazz Pharmaceuticals plc Investment FAQs
Steven Cohen first purchased Jazz Pharmaceuticals plc (JAZZ) in Q3 2015, acquiring 21,915 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Jazz Pharmaceuticals plc (JAZZ) for 36 quarters since Q3 2015.
Steven Cohen's largest addition to Jazz Pharmaceuticals plc (JAZZ) was in Q3 2021, adding 749,300 shares worth $97.57 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 175,000 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $29.75 M.
As of the Q4 2025 filing, Jazz Pharmaceuticals plc (JAZZ) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Jazz Pharmaceuticals plc (JAZZ) was 963,824 shares, as reported at the end of Q4 2021.